BK Technologies

BKTI
Financial Analysis · Updated April 14, 2026 · Coverage 2026-Q2

Financial Snapshot

Step 04 — Financial Quality Assessment

BK Technologies Corporation (BKTI)


1. Key Findings

Finding Detail Thesis Implication
No material GAAP-to-adjusted reconciliation exists BKTI reports under US-GAAP with minimal use of non-GAAP or "adjusted" metrics; management does not present adjusted EBITDA, adjusted EPS, or pro-forma figures in earnings releases [S2][S3] Positive — reduces risk of earnings quality manipulation; what you see is what you get
SBC is immaterial: $95K-$271K annually Stock-based compensation ranged from $55K (FY2018) to $271K (FY2023), representing <0.5% of revenue even in the worst year [S2] Positive — dilution from SBC is negligible; clean EPS is essentially GAAP EPS
No recurring "one-time" restructuring charges identified No restructuring charges, goodwill impairments, or acquisition-related costs appear in any year (FY2018-FY2025) [S2] Positive — the income statement is structurally clean; no addback inflation
FY2023 contains a large non-operating loss ($552K) and FY2024 a larger one ($839K in Q2 alone) Other non-operating expense items appear intermittently and are material relative to operating income in loss years [S2] Moderate concern — below-the-line items need scrutiny but are not being used to flatter operating metrics
Tax benefit of -$984K in FY2025 flatters net income BKTI recorded a tax benefit (negative tax expense) of $984K despite $7.8M operating income, likely from NOL carryforward utilization or valuation allowance release [S2] Mixed — boosts reported EPS by ~$0.26; normalized tax rate would reduce clean earnings; however, NOLs are a genuine economic asset
Share count discontinuity confirms reverse stock split Shares outstanding dropped from ~12.5-13.5M (FY2019-FY2021) to ~3.4M (FY2023+), consistent with an approximate 4:1 reverse split [S2] Neutral for quality — must be adjusted for cross-period EPS comparisons; not indicative of manipulation
No known short seller reports, fraud allegations, or class action lawsuits identified Adversarial sweep found no material legal, regulatory, or fraud-related red flags [S4][S5] Positive — clean adversarial profile for a company of this size
Clean operating earnings base for FY2025: ~$5.8-6.4M after tax normalization Adjusting FY2025 net income for tax normalization (applying ~20-25% effective rate) yields a sustainable earnings base materially below reported $8.4M Critical for valuation — reported EPS of $2.35 overstates normalized earning power; clean EPS is closer to $1.65-$1.80

2. Analysis

2.1 GAAP vs. Management-Adjusted Metrics

BKTI is a smaller reporting company that presents its results exclusively under US-GAAP [S1][S2]. A review of available earnings transcripts and press releases reveals that management does not present non-GAAP adjusted metrics such as adjusted EBITDA, adjusted operating income, or adjusted EPS [S3]. This is unusual in today's reporting environment and is a positive quality signal — there is no opportunity for management to selectively exclude costs to present a flattering picture.

The company's income statement line items are straightforward:

  • Revenue (from contract with customer)
  • Cost of goods and services sold
  • Gross profit
  • R&D expense
  • SG&A expense (with sub-components: G&A and Selling & Marketing)
  • Operating income/loss
  • Other non-operating items
  • Income tax expense/benefit
  • Net income/loss

There are no adjustments, pro-forma presentations, or non-GAAP reconciliations to evaluate [S2][S3]. The GAAP figures are the operating figures.

2.2 "One-Time" Charges Analysis (FY2018-FY2025)

A rigorous review of all available income statement line items across seven fiscal years reveals no restructuring charges, goodwill or intangible impairments, acquisition-related costs, or litigation settlements in any period [S2].

Detailed scan by category:

Category FY2018 FY2019 FY2020 FY2021 FY2023 FY2024 FY2025
Restructuring charges None None None None None None None
Goodwill impairment None None None None None None None
Asset impairment None None None None None None None
Acquisition costs None None None None None None None
Litigation settlements None None None None None None None
Inventory write-downs Not separately disclosed

Source: [S2] — All annual income statement data reviewed. Note: FY2022 data is not available in the dataset.

The only non-core items that appear are in the "OtherNonoperatingIncomeExpense" line:

Fiscal Year Other Non-Operating Income/(Expense) % of Revenue Notes
FY2018 ($106K) (0.3%) Immaterial [S2]
FY2019 ($328K) (0.7%) Minor [S2]
FY2020 ($104K) (0.3%) Immaterial [S2]
FY2021 ($169K) (0.4%) Immaterial [S2]
FY2023 ($552K) (1.1%) Notable — likely interest expense + other [S2]
FY2024 Not separately reported at annual level Q2 alone showed ($839K) non-operating expense [S2]
FY2025 Not separately broken out Tax benefit dominates below-the-line [S2]

Assessment: Non-operating items are small and not systematically used to flatter results. The FY2024 Q2 non-operating charge of $839K is notable but not repeated. There are no recurring "one-time" charges — the income statement is structurally clean.

2.3 Stock-Based Compensation (SBC) Analysis

SBC is explicitly disclosed in several periods and is immaterial across the entire time series [S2]:

Fiscal Year SBC ($) Revenue ($M) SBC as % of Revenue SBC as % of Operating Expense
FY2018 $55,000 $39.4M 0.14% <0.2%
FY2019 $95,000 $49.4M 0.19% <0.2%
FY2020 $148,000 $40.1M 0.37% <0.5%
FY2021 $129* $44.1M ~0.00% ~0.00%
FY2023 $271,000 $50.9M 0.53% <0.5%
FY2024 ~$177K** $74.1M 0.24% <0.3%
FY2025 Not separately disclosed $76.6M

FY2021 SBC of $129 appears to be a data error (likely $129K given the pattern) [S2] *FY2024 SBC estimated from quarterly data: Q1 $58K + Q2 $119K = $177K through Q2 [S2]

Dilution Impact:

  • Weighted average basic shares (FY2025): 3,553,303 [S2]
  • Weighted average diluted shares (FY2025): 3,710,644 [S2]
  • Dilution spread: ~157,341 shares, or 4.4% [S2]

This dilution spread suggests there are 157K dilutive securities outstanding (options/warrants), which at the current share price ($95-100 per share) represents ~$15M in potential dilution value. While the percentage dilution is not trivial (4.4%), the annual SBC cost flowing through the P&L is negligible — this suggests the dilutive securities are legacy instruments with low exercise prices rather than ongoing compensation grants.

Assessment: SBC is a non-issue for BKTI's financial quality. The gap between basic and diluted EPS ($2.35 vs. $2.25 in FY2025) [S2] is modest and reflects real dilutive instruments, not aggressive ongoing issuance.

2.4 Tax Rate Normalization — The Key Adjustment

The most significant financial quality issue for BKTI is the FY2025 tax benefit, which materially flatters reported net income:

Fiscal Year Pre-Tax Income Tax Expense/(Benefit) Effective Tax Rate Net Income
FY2018 ($5,133K)* ($1,824K) 35.5% benefit ($3,626K) [S2]
FY2019 $2,097K* ($277K) -13.2% (benefit) ($195K) [S2]
FY2020 ($4,489K)* ($987K) 22.0% benefit ($2,636K) [S2]
FY2021 $197K* ($3K) -1.5% $194K [S2]
FY2023 ($11,633K) $0 0.0% ($11,633K) [S2]
FY2024 ($2,176K)* $54K -2.5% ($2,230K) [S2]
FY2025 $7,375K* ($984K) -13.3% (benefit) $8,359K [S2]

Pre-tax income calculated as Net Income + Tax Expense

In FY2025, BKTI reported $7.4M in pre-tax income but booked a $984K tax benefit, resulting in net income of $8.4M [S2]. This means the company's net income is higher than its pre-tax income — a clear signal that a valuation allowance release or NOL carryforward utilization inflated earnings.

The company accumulated significant net operating losses during FY2018-FY2024, during which it generated cumulative pre-tax losses of approximately $21M+. These NOLs create a deferred tax asset, against which BKTI likely maintained a full or partial valuation allowance. As the company returned to profitability in FY2025, it likely reversed a portion of this allowance, generating the tax benefit [S2].

Normalization:

  • FY2025 pre-tax income: $7,375,000 [S2]
  • At a normalized statutory rate of 21%: tax would be ~$1,549K
  • At a blended effective rate of 15% (reflecting some ongoing NOL benefit): tax would be ~$1,106K
  • Normalized net income range: $5,826K - $6,269K
  • Normalized EPS (basic): $1.64 - $1.76 vs. reported $2.35 [S2]

This represents a 30-35% reduction from reported net income — a critical adjustment for any DCF or earnings-multiple valuation.

2.5 Metric Definition Changes Over Time

Several inconsistencies in line-item naming have been identified [S2]:

Issue Periods Affected Impact
Revenue labeled as Revenues vs. RevenueFromContractWithCustomerIncludingAssessedTax FY2018-FY2021 use Revenues; FY2024-FY2025 use RevenueFromContract... No economic difference — reflects ASC 606 adoption labeling
COGS labeled as CostOfRevenue vs. CostOfGoodsAndServicesSold FY2018-FY2021 use CostOfRevenue; FY2023+ use CostOfGoodsAndServicesSold No economic difference — same concept
FY2019 and FY2018 show small negative CostOfGoodsAndServicesSold (-$38K, +$149K) alongside full CostOfRevenue FY2018-FY2019 Likely XBRL tagging artifact — CostOfRevenue is the correct figure
R&D expense not reported for FY2021 FY2021 data gap Unable to verify R&D spending for this period [S2]
SBC not separately disclosed for FY2025 FY2025 Likely embedded in SG&A — magnitude estimated as immaterial based on historical pattern

Assessment: These are XBRL taxonomy labeling changes, not substantive definition changes. There is no evidence of management changing how it calculates or presents any metric over time. This is a positive quality signal.

2.6 Adversarial Research Sweep

A comprehensive adversarial sweep was conducted covering:

Category Finding Source
Short seller reports None identified [S4][S5] — No Hindenburg, Muddy Waters, Citron, or other activist short reports found
Fraud allegations None identified [S4][S5] — No SEC enforcement actions, DOJ investigations, or whistleblower complaints found
Regulatory investigations None identified SEC filings show no disclosed investigations or consent orders [S1]
Class action lawsuits None identified No securities fraud class actions found in PACER or legal databases [S4][S5]
Auditor issues BKTI uses a smaller audit firm (consistent with its size); no going concern opinions in available filings [S1]
Restatements None identified in the filing history [S1][S2]
Related party transactions None identified as material [S1]
Insider selling patterns Not evaluated in this step — requires separate data source

Assessment: BKTI has a clean adversarial profile. This is consistent with a small, niche defense/public-safety hardware company that has limited Street coverage and a straightforward business model. The absence of red flags does not guarantee quality, but it removes a category of risk.

2.7 Clean Operating Earnings Base for Valuation

Based on the above analysis, the following adjusted earnings framework is established:

FY2025 Clean Operating Earnings Build:

Line Item Reported ($000) Adjustment Clean ($000) Notes
Revenue $76,592 None $76,592 [S2]
COGS ($47,542) None ($47,542) [S2]
Gross Profit $29,050 $29,050 37.9% margin
R&D ($7,841) None ($7,841) Ongoing cost of business — not adjustable [S2]
SG&A ($21,222) Add back ~$200K SBC* ($21,022) SBC estimate based on historical pattern
Clean Operating Income $187 net impact ~$8,028K, or 10.5% margin
Depreciation & Amortization Not separately disclosed Requires cash flow data
EBITDA (estimated) ~$9.0-9.5M Estimate: OpInc + ~$1.0-1.5M D&A**
Normalized taxes @ 21% ($1,686K) Applied to clean operating income
Interest/Other Assume ~($200K) ($200K) Based on historical run rate
Normalized Net Income ~$6,142K
Normalized EPS (basic) ~$1.73 vs. reported $2.35
Normalized EPS (diluted) ~$1.66 vs. reported $2.25

SBC add-back is immaterial and included for completeness *D&A not separately disclosed in income statement data; estimated from company's asset base and historical patterns

Alternative scenarios for normalized tax rate:

Tax Rate Assumption Normalized Net Income ($000) Normalized Diluted EPS Rationale
0% (full NOL shield, 2-3 years) ~$7,828 ~$2.11 If NOLs shield all income near-term
15% (partial NOL benefit) ~$6,654 ~$1.79 Moderate assumption
21% (full statutory) ~$6,142 ~$1.66 Long-term steady state
25% (state + federal blended) ~$5,871 ~$1.58 Conservative estimate

3. Evidence and Sources

Citation Source Description
[S1] SEC EDGAR — BKTI Annual Reports (10-K filings) Company description, accounting policies, segment disclosure, NOL information
[S2] XBRL Financial Data — Annual and Quarterly All income statement, balance sheet, and share count data referenced throughout
[S3] Earnings Transcripts / Press Releases Management commentary on financial results; absence of non-GAAP metrics
[S4] Adversarial sweep — public legal databases, short seller report aggregators No adverse findings
[S5] Web search results No class actions, fraud allegations, or regulatory actions identified

4. Thesis Impact

Net Assessment: POSITIVE — with one critical caveat

Positive factors:

  • No earnings quality manipulation. BKTI does not present non-GAAP metrics, does not layer on recurring "one-time" charges, and does not use aggressive adjustments. The GAAP statements are the truth.
  • SBC is a non-issue. At <0.5% of revenue, stock-based compensation creates negligible dilution and negligible P&L impact.
  • Clean adversarial profile. No short seller reports, fraud allegations, lawsuits, or restatements.
  • No restructuring or impairment charge history. Seven years of data show zero restructuring, impairment, or acquisition charges — this is a company that has not needed to take big baths.
  • Straightforward financial statements. Single segment, single geography, single product category — there is limited room for inter-segment allocation games or geographic profit shifting.

The critical caveat — tax normalization:

  • FY2025 reported net income of $8.4M is overstated by ~$2.2-2.5M relative to a normalized tax environment. Reported EPS of $2.35 should be treated as ~$1.65-$1.80 for valuation purposes. At a market cap of ~$349M, the P/E on reported earnings is ~40x; on normalized earnings, it is ~53-57x — a materially less attractive entry point.
  • However, the NOL asset is real and provides 2-3 years of cash tax savings that have genuine economic value (estimated cumulative NOL of $15-20M, worth $3-4M in tax savings).

Updated Thesis Tracker:

Step Finding Impact Cumulative
00 Data foundation established Neutral Neutral
01 Business model analyzed Neutral Neutral
02 Positive Positive
03 Mixed Mixed
04 Financial quality is high; tax normalization reduces clean EPS ~30% Mixed Mixed

5. Open Questions

# Question Why It Matters Resolution Path
1 What is BKTI's total NOL carryforward balance? Determines how many years of tax-free earnings remain; affects DCF cash flow projections 10-K tax footnote review
2 What is the exact nature of the FY2025 tax benefit? Valuation allowance release vs. R&D tax credit vs. other — affects sustainability 10-K income tax note
3 What is D&A expense? Required to compute EBITDA and reconcile operating income to cash flow Cash flow statement analysis (Step 05)
4 Are there material warranty reserves or deferred revenue balances? Could indicate hidden liabilities or unrecognized revenue Balance sheet / footnote review
5 What explains the $839K non-operating charge in FY2024-Q2? If recurring, it reduces normalized earnings; if one-time, it can be excluded 10-Q filing review
6 Has BKTI's auditor issued any qualified opinions or material weakness findings? Small-company audit quality is a known risk factor 10-K audit opinion review
7 What is the dilutive security composition (options vs. warrants vs. RSUs)? Affects future dilution trajectory and SBC expense forecast Equity footnote in 10-K
8 Does BKTI capitalize any development costs? If R&D is partially capitalized, reported R&D expense understates true spending Balance sheet intangible asset analysis

Deeper Financial Analysis

The fundamental tier adds 8 additional research dimensions for $BKTI.

Revenue Breakdown
Segment revenue, geographic mix, product-line contribution margins, and cohort dynamics.
Financial Trends
Quarter-over-quarter momentum, leading indicators, and inflection point analysis.
Balance Sheet
Debt structure, liquidity runway, dilution risk, and working capital dynamics.
Capital Allocation
ROIC trends, buyback cadence, M&A appetite, and reinvestment efficiency.
GET /api/v1/research/BKTI/fundamental$1.00 · Bearer token required
Markdown: /stocks/bkti/financials/md · → thesis · → memo